Enterprise Value
-13.64M
Cash
270.3M
Avg Qtr Burn
-28.12M
Short % of Float
10.05%
Insider Ownership
11.32%
Institutional Own.
81.19%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CFT1946 Details Cancer, Solid tumor/s | Phase 1/2 Data readout | |
CFT7455 Details Non-Hodgkin lymphoma, Blood cancer, Multiple myeloma | Phase 1/2 Data readout | |
CFT8634 (BiDAC) Details Rare diseases, Cancer | Phase 1/2 Data readout | |
CFT8919 (EGFR) Details Solid tumor/s, Non-small cell lung carcinoma, Cancer | IND Submission |